Ultragenyx Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares
November 02, 2020 at 14:22 PM EST
Ultragenyx Pharmaceutical Inc., today announced the closing of its previously announced underwritten public offering of 5,111,110 shares of its common stock, including the exercise in full by the underwriters of their option.
